Algorae Pharmaceuticals Limited
LVCLF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $12,452 | $4,218 | $16,442 | $18,049 |
| - Cash | $469 | $307 | $3,108 | $622 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $11,982 | $3,911 | $13,334 | $17,427 |
| Revenue | $0 | $0 | $125 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $125 | $0 |
| % Margin | – | – | 100% | – |
| EBITDA | $0 | $0 | -$430 | -$574 |
| % Margin | – | – | -343.7% | – |
| Net Income | -$150 | -$653 | -$644 | -$1,451 |
| % Margin | – | – | -514.8% | – |
| EPS Diluted | -0 | -0 | -0 | -0.001 |
| % Growth | 75% | 0% | 55.6% | – |
| Operating Cash Flow | -$0 | -$1 | -$515 | -$1,009 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$1 | -$515 | -$1,009 |